Evotec announces progress in strategic protein degradation research collaboration with Bristol Myers Squibb: Hamburg, Northern Germany Saturday, April 26, 2025, 13:00 Hrs [IST] Ev ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure.

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics (NASDAQ: KYMR) notched an almost 23% share ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...

With this level of control, scientists can fine-tune how nanomedicines interact with the human body. These new designs are ...

Scientists have developed a powerful new injectable treatment that, when administered after a heart attack, helps the heart ...

DiaMedica Therapeutics Inc.’s DMAC share price has dipped by 7.41%, which has investors questioning if this is right time to ...